Trial Profile
A retrospective, observational study evaluating efficacy and safety of perampanel treatment in epilepsy patients in South Korea
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2018
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 27 Apr 2018 Results assessing efficacy and tolerability of Perampanel in epilepsy patients, presented at the 70th Annual Meeting of the American Academy of Neurology.
- 08 Dec 2017 New trial record
- 01 Dec 2017 Results published in the Clinical Neuropharmacology